STOCK TITAN

[Form 3] ImageneBio, Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

ImageneBio, Inc. director Jonathan Jian Wang submitted an initial Form 3 reporting no securities beneficially owned as of the event date 07/25/2025. The filing notes it was submitted late because the reporting person experienced delays obtaining EDGAR access codes; the form is signed by an attorney-in-fact on 08/15/2025. No non-derivative or derivative holdings are disclosed.

ImageneBio, Inc. direttore Jonathan Jian Wang ha presentato un primo Modulo 3 riportando nessuna titolarità di titoli detenuti in modo beneficiario al 25/07/2025. La dichiarazione di presentazione indica che è stato consegnato in ritardo a causa dei ritardi nell'ottenere i codici di accesso EDGAR; il modulo è firmato da un procuratore ad acta il 15/08/2025. Non sono divulgate partecipazioni non derivate né derivate.

ImageneBio, Inc. director Jonathan Jian Wang presentó un Form 3 inicial reportando no se poseen valores en beneficio propio a la fecha del evento 25/07/2025. La presentación indica que se presentó tarde debido a que la persona que reporta experimentó retrasos para obtener los códigos de acceso EDGAR; el formulario está firmado por un apoderado el 15/08/2025. No se divulgan participaciones no derivadas ni derivadas.

ImageneBio, Inc. 이사 Jonathan Jian Wang은(는) 최초의 Form 3를 제출하며 이벤트 날짜 2025-07-25 기준으로 실소유의 증권이 없음을 보고했습니다. 제출은 보고자가 EDGAR 접속 코드 확보에 지연이 있어 지연 제출되었음을 기록하며; 이 양식은 2025-08-15에 대리인에 의해 서명되었습니다. 비파생 또는 파생 보유는 공개되지 않았습니다.

ImageneBio, Inc. administrateur Jonathan Jian Wang a soumis un Form 3 initial déclarant aucun titre détenu de manière bénéficiaire au 25/07/2025. Le dossier indique qu'il a été soumis en retard en raison des retards rencontrés par la personne déclarant pour obtenir les codes d'accès EDGAR ; le formulaire est signé par un mandataire le 15/08/2025. Aucune détention non dérivée ou dérivée n'est divulguée.

ImageneBio, Inc. Direktor Jonathan Jian Wang hat einen ersten Form 3 eingereicht und berichtet keine Wertpapiere, die begünstigt gehalten werden per Stichtag 25.07.2025. Die Einreichung vermerkt, dass sie verspätet eingereicht wurde, weil die meldende Person Verzögerungen beim Erhalt von EDGAR-Zugangscodes erlebte; das Formular ist am 15.08.2025 von einem Bevollmächtigten unterzeichnet. Es werden keine nicht-derivative oder derivative Beteiligungen offengelegt.

ImageneBio, Inc. مدير Jonathan Jian Wang قدم نموذجاً أولياً Form 3 يذكر لا توجد أسهم مملوكة بشكل منفعة مستفاد حتى تاريخ الحدث 25/07/2025. تشير الإيداع إلى أنه تم تقديمه متأخراً بسبب تأخر الشخص المبلغ عن الحصول على رموز وصول EDGAR؛ تم توقيع النموذج من قِبل محامٍ وكيل بتاريخ 15/08/2025. لا يتم الكشف عن أية ممتلكات غير مشتقة أو مشتقة.

ImageneBio, Inc. 董事 Jonathan Jian Wang 提交了初始表格 Form 3,按事件日期 2025/07/25 报告 不拥有受益所有权的证券。 文件称其提交延迟是因为申报人获取 EDGAR 访问代码时出现延误;该表格由一名代理律师在 2025/08/15 签署。 未披露非衍生品或衍生品持股。

Positive
  • None.
Negative
  • Late filing due to delays obtaining EDGAR access codes, signed 08/15/2025

Insights

Director filed an initial Form 3 reporting zero holdings and a late submission due to EDGAR access delays.

This Form 3 explicitly states no securities are beneficially owned by the reporting director as of the event date 07/25/2025, so there is no disclosed change in ownership to affect shareholder stakes.

The filing also records a late submission attributed to delays obtaining EDGAR codes and is signed on 08/15/2025; this documents a procedural lapse but contains no other compliance violations or corrective actions disclosed in the filing.

ImageneBio, Inc. direttore Jonathan Jian Wang ha presentato un primo Modulo 3 riportando nessuna titolarità di titoli detenuti in modo beneficiario al 25/07/2025. La dichiarazione di presentazione indica che è stato consegnato in ritardo a causa dei ritardi nell'ottenere i codici di accesso EDGAR; il modulo è firmato da un procuratore ad acta il 15/08/2025. Non sono divulgate partecipazioni non derivate né derivate.

ImageneBio, Inc. director Jonathan Jian Wang presentó un Form 3 inicial reportando no se poseen valores en beneficio propio a la fecha del evento 25/07/2025. La presentación indica que se presentó tarde debido a que la persona que reporta experimentó retrasos para obtener los códigos de acceso EDGAR; el formulario está firmado por un apoderado el 15/08/2025. No se divulgan participaciones no derivadas ni derivadas.

ImageneBio, Inc. 이사 Jonathan Jian Wang은(는) 최초의 Form 3를 제출하며 이벤트 날짜 2025-07-25 기준으로 실소유의 증권이 없음을 보고했습니다. 제출은 보고자가 EDGAR 접속 코드 확보에 지연이 있어 지연 제출되었음을 기록하며; 이 양식은 2025-08-15에 대리인에 의해 서명되었습니다. 비파생 또는 파생 보유는 공개되지 않았습니다.

ImageneBio, Inc. administrateur Jonathan Jian Wang a soumis un Form 3 initial déclarant aucun titre détenu de manière bénéficiaire au 25/07/2025. Le dossier indique qu'il a été soumis en retard en raison des retards rencontrés par la personne déclarant pour obtenir les codes d'accès EDGAR ; le formulaire est signé par un mandataire le 15/08/2025. Aucune détention non dérivée ou dérivée n'est divulguée.

ImageneBio, Inc. Direktor Jonathan Jian Wang hat einen ersten Form 3 eingereicht und berichtet keine Wertpapiere, die begünstigt gehalten werden per Stichtag 25.07.2025. Die Einreichung vermerkt, dass sie verspätet eingereicht wurde, weil die meldende Person Verzögerungen beim Erhalt von EDGAR-Zugangscodes erlebte; das Formular ist am 15.08.2025 von einem Bevollmächtigten unterzeichnet. Es werden keine nicht-derivative oder derivative Beteiligungen offengelegt.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Wang Jonathan Jian

(Last) (First) (Middle)
C/O IMAGENEBIO, INC.
12526 HIGH BLUFF DRIVE

(Street)
SAN DIEGO CA 92130

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/25/2025
3. Issuer Name and Ticker or Trading Symbol
ImageneBio, Inc. [ IMA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit 24 - Power of Attorney. This Form 3 is being filed late due to delays in obtaining the reporting person's EDGAR codes.
No securities are beneficially owned.
/s/ Jotin Marango, Attorney-in-Fact 08/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Jonathan Jian Wang report on Form 3 for ImageneBio (IMA)?

The filing states no securities are beneficially owned by Jonathan Jian Wang as of 07/25/2025.

Was the Form 3 filed on time for ImageneBio (IMA)?

No; the Form 3 notes it was filed late due to delays obtaining the reporting person's EDGAR codes and is signed on 08/15/2025.

Does the Form 3 disclose any derivative holdings for the reporting person?

No; Table I and Table II contain no reported non-derivative or derivative securities.

Who signed the Form 3 for the reporting person?

The Form 3 is signed by /s/ Jotin Marango, Attorney-in-Fact on 08/15/2025.
ImageneBio

NASDAQ:IMA

IMA Rankings

IMA Latest News

IMA Latest SEC Filings

IMA Stock Data

92.03M
9.21M
14.24%
33.27%
0.09%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
BOSTON